UCL Centre for Nanotechnology & Regenerative Medicine, UCL Division of Surgery & Interventional Science, University College London, London NW3 2QG, UK.
Adv Drug Deliv Rev. 2013 Mar;65(3):357-67. doi: 10.1016/j.addr.2012.06.014. Epub 2012 Jul 20.
Exosomes are biological membrane vesicles measuring 30 to 100 nm. They contain an abundance of small molecules like tetraspanins, receptors for targeting and adhesion, lipids, and RNA. They are secreted by most biological cells, and are involved in a plethora of physiological functions including, but not limited to, transport of genetic material, modulation of the immune system, and cell-to-cell communication. It has been further reported that exosomes utilize a mechanism similar to that of viruses for gaining entry into cells. Due to their viral-like transfection efficiency and inherent biological function, compelling evidence indicates that exosomes can be used as novel delivery platforms for gene therapy. Furthermore, RNA-containing exosomes derived from cells can serve as functional genetic biomarkers for diseases. This twin modality of therapeutic and diagnostic is termed theranostics in the emerging field of nanomedicine. Hence in this review, we seek to expound on the various facets of exosomes, highlighting their significance in and relevance to nano-theranostic platforms for gene therapy.
外泌体是一种生物膜囊泡,大小为 30 至 100nm。它们包含丰富的小分子,如四跨膜蛋白、靶向和黏附受体、脂质和 RNA。它们由大多数生物细胞分泌,并参与多种生理功能,包括但不限于遗传物质的运输、免疫系统的调节和细胞间通讯。此外,有报道称外泌体利用类似于病毒的机制进入细胞。由于其类似病毒的转染效率和固有生物学功能,大量证据表明外泌体可用作基因治疗的新型递送平台。此外,源自细胞的含有 RNA 的外泌体可用作疾病的功能遗传生物标志物。这种治疗和诊断的双重模式在新兴的纳米医学领域被称为治疗诊断学。因此,在这篇综述中,我们旨在阐述外泌体的各个方面,强调它们在基因治疗的纳米治疗诊断平台中的重要性和相关性。